Pulmonary Edema Market size was valued at USD 6.6 bn in 2024, and the total Pulmonary Edema revenue is expected to grow at a CAGR of 7.8 % from 2025 to 2032, reaching nearly USD 12.04 bn by 2032.

Stellar Market Research published a report "Pulmonary Edema Market and forecast (2025-2032)." The report is a comprehensive analysis of Pulmonary Edema Market share, size, growth, trends, and forecast. The report also contains competitor analysis and regional analysis and gives attention to the recent market trend.

Pulmonary edema is an ailment that comprises an excess amount of fluid in the lungs and poor oxygen intake and breathing. Pulmonary Edema Market comprises healthcare services, therapies, and medical devices utilized to diagnose and treat an excess amount of fluid. Developments in drugs, non-invasive respiratory therapy, and advanced diagnosis are improving the efficiency of treatment. Knowledge of the condition, and moving from conventional means of care to individualized and home-based care, will also be driving the Pulmonary Edema Market towards better outcomes and quality of life for patients.

Download your complimentary sample copy of this report! https://www.stellarmr.com/report/req_sample/pulmonary-edema-market/2673

Pulmonary Edema Market Dynamics

Rising Prevalence of Cardiovascular System

Pulmonary edema usually arises as a complication of certain underlying conditions like congestive heart failure, coronary artery disease, COPD, and ARDS. Global increases in these conditions due to aging populations, physical inactivity, and poor diets are swelling the ranks of at-risk patients, driving demand for pulmonary edema therapies.

Increasing Incidence of Road Accidents

Growing rates of road accidents are leading to more frequent chest injuries, including blunt trauma, which can cause pulmonary edema through injury or inflammation of lung tissue. These conditions need immediate medical treatment in the form of imaging diagnostics, respiratory therapy, and critical care. This need for pulmonary edema treatment options like ventilators, oxygen therapy, and associated drugs is growing, thus making pulmonary complications arising from trauma one of the drivers of growth in the market.

Pulmonary Edema Market Segment Analysis

Based on Disease Type

By disease type, the market can be classified into cardiogenic and non-cardiogenic pulmonary edema. Cardiogenic pulmonary edema typically has a larger share in the market because the incidence of heart diseases such as coronary artery disease and congestive heart failure, which are causing fluid to accumulate in the lungs, is greater than lung injuries or infections, which causes non-cardiogenic pulmonary edema.

Based on Diagnosis Type

The main parts for diagnosis are tests that use imaging, blood tests, and echocardiograms. Imaging tests are important to this part of segmenting because they are the most frequently used and recognized way to identify fluid build-up and measure health of lungs, which is essential for quick identification and diagnosis.

Based on End User

The end users include hospitals, specialty clinics, homecare, and ambulatory surgical centers. Hospitals are the largest end-user segment because pulmonary edema generally requires emergency response, intensive care, and multi-disciplinary services, all of which hospitals are able to provide.

To learn more about the findings of this research, please check: https://www.stellarmr.com/report/pulmonary-edema-market/2673

Pulmonary Edema Market Regional Analysis

North America

North America is the leading region in Pulmonary Edema Market, because of expanded healthcare systems, well-structured medical technology, and high expenditure on medical care. The occupational end-users are most aware of the existence of cardiovascular and respiratory diseases, which contribute to pulmonary edema, than any other regions. Relative to the available patient population in North America, the awareness related to some cardiac or respiratory conditions contributing to pulmonary edema is significant.

Europe

Europe has a large segment of the market backed by a growing older population with heart and lung disease. Many European countries already have a responsive healthcare system with tools for advanced treatment and diagnosis. The growth of the market over the next few years in Europe will also be driven by increasing governmental initiatives around cardiovascular health, more capital investment in healthcare infrastructure.

Pulmonary Edema Market Competitive Landscape

Aiolos Bio by GSK (January 2024): GSK acquired Aiolos Bio a clinical-stage biopharmaceutical company which was focused on providing treatment options for respiratory and inflammatory effects. This acquisition aligned with the increased requirements in respiratory care and provided GSK with a more mixed portfolio of respiratory care options due to market demand in effective pulmonary edema treatment.

AstraZeneca's Purchase of Amolyt Pharma (March 2024): AstraZeneca announced a definitive agreement to acquire clinical-stage biopharmaceutical company Amolyt Pharma, developing treatments for rare endocrine diseases. This acquisition could have an impact on the management of pulmonary edema in patients with comorbid endocrine disease.

Recent Development

In April 2023, ResMed acquired Propeller Health, enhancing its portfolio in digital health solutions for respiratory diseases, including pulmonary edema.
In March 2023, AstraZeneca entered into a collaboration with BioNTech to develop novel immune-oncology therapies for various disease indications, including pulmonary edema associated with lung cancer.
Don't miss the latest industry insights from Stellar Market Research’s trending reports:

Liechtenstein Dental Trauma Market https://www.stellarmr.com/report/Liechtenstein-Dental-trauma-Market/635

Mea Endoscopic Retrograde Cholangiopancreatography Market https://www.stellarmr.com/report/MEA-Endoscopic-Retrograde-Cholangiopancreatography-Market/772

About Stellar Market Research:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Stellar Market Research:

S.no.8, h.no. 4-8 Pl.7/4, Kothrud,

Pinnac Memories Fl. No. 3, Kothrud, Pune,

Pune, Maharashtra, 411029

[email protected]

+91 20 6630 3320, +91 9607365656